Multiple Myeloma Survivor - John's Envita Review
John had always experienced back pain from injuries in his past, but this time the pain would not subside, and he could barely walk without being in significant discomfort. There were days when he could not get out of bed even to eat, because he knew his back would hurt as soon as he stood up. To investigate the root cause of his problem, John got his blood work done and the results pointed towards cancer. However, he never received an accurate diagnosis in conventional care. “I wasn't really diagnosed with Multiple Myeloma, until I got to Envita,” said John, a resident of Mississippi, who came to Envita Medical Centers in Arizona with the hope of getting better. Multiple myeloma is a type of bone marrow cancer, and its diagnosis requires a bone marrow biopsy, which was not while John was in standard care.
Disclaimer: Individual results will vary. Envita makes no guarantees for outcomes. Each patient case is unique. Please consult your doctor before making any changes to your medical treatment. Not every patient is a candidate for care or achieves these results. Treatments used in this case may not all be FDA approved for the treatment of this condition.
John's quest for more personalized treatment of his cancer led him to Envita Medical Centers, a world-class integrative center of precision oncology which combines the latest in conventional care with advanced natural therapies for improving patient outcomes. With over twenty years of clinical experience treating late stage and refractory to care cancer patients, Envita has developed sophisticated algorithms designed to target each patient's specific cancer cell mutations, based off their unique medical blueprint. The specialists at Envita understand that cancer is a disease of genetic mutations and each patient's genetic mutations are different, even if they have the same stage and type of cancer.
Envita's customized treatment approach is based on advanced proprietary testing of genomics, proteomics, metabolomics, and the immuno-responsive targets of each individual patient. An analysis of all these parameters helps them custom-build the medications, which are targeted to attack each patient's root cause of the cancer. Envita uses advanced medicine-deployment mechanisms like Genetically Targeted Fractionated Chemotherapy (GTFC™), which are aimed at reducing toxicity, improving quality of life, and enhancing longevity.
GTFC™ delivers metronomic doses of chemotherapy, designed to impact only the cancer cells and not the healthy cells of the body, potentially improving cancer kill while reducing the side-effects of a weakened immune system as seen in conventional chemotherapy. A stronger immune system is better equipped to fight back cancer growth and progression. “I wouldn't want to see you get any other kind of treatment,” said John. He is optimistic about being on this path of holistic healing and hopes to gain an edge over his cancer.
John is very satisfied with his decision to come to Envita Medical Centers for his treatment. He hopes all cancer patients get access to these advanced treatment options in precision oncology, so they have a better chance at life. The specialist team including oncologists, interventional radiologists, researchers, and pharmacists, aim to unravel the drivers of your cancer and target them from all possible angles so you can achieve long term remission. If you or your loved ones have any questions regarding cancer, please do not hesitate to call our Patient Care Expert Team at 866-830-4576.
